Sign In
Buy DLB
$58.81
+7.03 (+13.58%)
At Close: Jul 31, 2026
Why Dolby Labs Stock Popped Today
11:02am, Friday, 31'st Jul 2026
Dolby beat on earnings but missed on sales last night. Both earnings and sales declined year over year -- but should improve in Q4.
Dolby's Q3 Earnings Beat Estimates on Lower Operating Expenses
09:06am, Friday, 31'st Jul 2026
DLB beat Q3 earnings estimates despite lower revenue, then forecast strong Q4 growth backed by video licensing, autos and new device categories.
Dolby Laboratories Q3 Earnings Call Highlights
02:05am, Friday, 31'st Jul 2026
Dolby Laboratories NYSE: DLB reported third-quarter fiscal 2026 revenue of $305 million, within its prior guidance range, as strength in Dolby Atmos, Dolby Vision and imaging patents was partly offset
Dolby Laboratories (DLB) Q3 Earnings Beat Estimates
08:31pm, Thursday, 30'th Jul 2026
Dolby Laboratories (DLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.78 per share a year ago.
Dolby Laboratories (DLB) Reports Q3 Earnings: What Key Metrics Have to Say
08:01pm, Thursday, 30'th Jul 2026
Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wal
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
07:43pm, Thursday, 30'th Jul 2026
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
Dolby Laboratories Reports Third Quarter 2026 Financial Results
04:15pm, Thursday, 30'th Jul 2026
SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against
Aristotle Global Equity Advisory Q2 2026 Portfolio Review
01:20am, Thursday, 30'th Jul 2026
For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return of 6.92% pure gross of fees (6.40% net of fees), underperforming the MSCI ACWI Index, which returne
Dolby Laboratories Valuation Is Compelling Ahead Of Earnings
10:18am, Monday, 20'th Jul 2026
Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2026 Financial Results
04:15pm, Tuesday, 14'th Jul 2026
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the third quarter (Q3) fiscal yea
BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain
10:07am, Friday, 26'th Jun 2026
Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FDA's feedback gave their planned pivotal program a clearer path. Basically, DLB psychosis has no appr
- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease - - Company Developing NPI as a Measure of DLB Psychosis -
3 Audio Video Stocks to Watch as Industry Witnesses Headwinds
02:00pm, Wednesday, 10'th Jun 2026
Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.
Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics
10:00am, Tuesday, 09'th Jun 2026
Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [url="]7060XE7 Series[/url], a new portfolio of 1.6T networki
